SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-012393
Filing Date
2018-05-09
Accepted
2018-05-09 16:06:38
Documents
65
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arna-10q_20180331.htm 10-Q 1594713
2 EX-31.1 arna-ex311_7.htm EX-31.1 15024
3 EX-31.2 arna-ex312_6.htm EX-31.2 15402
4 EX-32.1 arna-ex321_8.htm EX-32.1 8782
  Complete submission text file 0001564590-18-012393.txt   7175151

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT arna-20180331.xml EX-101.INS 1796211
6 XBRL TAXONOMY EXTENSION SCHEMA arna-20180331.xsd EX-101.SCH 53977
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arna-20180331_cal.xml EX-101.CAL 54461
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arna-20180331_def.xml EX-101.DEF 177490
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE arna-20180331_lab.xml EX-101.LAB 393823
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arna-20180331_pre.xml EX-101.PRE 302814
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31161 | Film No.: 18818280
SIC: 2834 Pharmaceutical Preparations